Motif Bio confident about partner interest in Iclaprim
Graham Lumsden, chief executive of Motif Bio (LON:MTFB), tells Proactive Investors he is confident about the path forward for Iclaprim. After a ‘collaborative meeting’ with the FDA, the American regulator gave the biopharmaceutical company the green light to begin phase 111 clinical trials on its next-generation antibiotic. Lumsden is now putting together a strategic business …Read more »
GGN: New BC for Men Explodes Sperm, Robot to Dispense Prescriptions, 3000 Dead Birds in Peru/Chile
PLEASE SUBSCRIBE Please visit: http://www.ggnonline.com or http://www.youtube.com/user/DDarko2013 for the latest news commentary by Global Government News Please visit http://www.ggnonline.com to donate to GGN because it would be greatly appreciated. Thank you. HEADLINES WITH LINKS: Obama Challenges Women to Lead the Way http://bit.ly/JUrpcn Somali draft constitution includes women in country’s affairs http://bit.ly/JrGJCi Population Control: UK aid …Read more »
Hassan Sees Drug Industry as `Partner’ on Health Care: Video
Feb. 19 (Bloomberg) — Fred Hassan, a senior adviser at Warburg Pincus LLC, talks with Bloomberg’s Peter Cook about President Barack Obama’s plan to release a proposal to restart the health-care debate before a bipartisan White House meeting on Feb. 25. Hassen, who is the former chief executive officer of Schering-Plough Corp., also discusses the …Read more »
Dr Peter Gøtzsche exposes big pharma as organized crime
For more informative videos and free information visit http:drmcdougall.com Peter C. Gøtzsche, MD is a Danish medical researcher, and leader of the Nordic Cochrane Center at Rigshospitalet in Copenhagen, Denmark. He has written numerous reviews within the Cochrane collaboration. Dr.Gøtzsche has been critical of screening for breast cancer using mammography, arguing that it cannot be …Read more »
Death by Fentanyl, Part 1: The ‘serial killer’ of drugs
A dangerous opiate called fentanyl is turning one of the worst drug epidemics in U.S. history even deadlier. In the The Naked Truth’s series premiere, Fusion correspondent Mariana van Zeller traces the drug’s two sources: pharmaceutical companies and Mexican drug lords.